---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-053458"
form_type: "8-K"
ticker: "WTI"
cik: "0001288403"
company_name: "W&T OFFSHORE INC"
filed_at: "2023-05-01T23:59:59+00:00"
generated_at: "2026-06-16T04:44:18.058718+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# W&T Offshore appoints Dr. Nancy Chang as independent director, effective April 28, 2023

## Summary
- Board expanded to five members; Dr. Chang appointed to Audit and NCG Committees and as Chair of ESG Committee.
- Dr. Chang previously CEO of Ansun Biopharma, co-founder/CEO of Tanox, and founder of Apex Capital; extensive board experience.
- Will receive standard non-employee director compensation; entered into indemnification agreement with the company.
- Press release issued May 1, 2023; Dr. Chang will stand for election at upcoming annual meeting.

## SEC filing metadata
- accession: 0001104659-23-053458
- form_type: 8-K
- ticker: WTI
- cik: 0001288403
- company_name: W&T OFFSHORE INC
- filed_at: 2023-05-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1288403/000110465923053458/0001104659-23-053458-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1288403/000110465923053458/tm2313484d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-053458
- JSON: https://secwatch.observer/filing/0001104659-23-053458.json
- Plain text: https://secwatch.observer/filing/0001104659-23-053458.txt

## Key facts
- Executive change
  Dr. Nancy Chang was appointed as Director at W&T OFFSHORE INC.
  - Action: appointed
  - Role: Director
  source text: On May 1, 2023, W&T Offshore, Inc. (the “Company”) announced that its Board of Directors (the “Board”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, voted to expand the size of the Board to five members and appointed Dr. Nancy Chang to fill the vacancy on the Board on April 28, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1288403/000110465923053458/0001104659-23-053458-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.